Duvelisib bulk supplier for pharma manufacturers

Duvelisib 15mg, 25mg Suppliers & Bulk Manufacturers

Available Forms: Capsules

Available Strengths: 15mg, 25mg

Reference Brands: Copiktra (USA/EU)

Duvelisib is an oral phosphoinositide 3-kinase (PI3K) inhibitor used to treat adults with relapsed or refractory chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and follicular lymphoma (FL). It works by blocking PI3K-delta and PI3K-gamma enzymes, which play key roles in cancer cell survival and proliferation. Copiktra helps slow the growth of malignant cells and reduce tumor progression.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Duvelisib — third party manufacturing & bulk supply

Duvelisib 15mg, 25mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Duvelisib is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Duvelisib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Duvelisib →

Back to Listing

Frequently Asked Questions

Duvelisib is listed as Capsules in 15mg, 25mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Duvelisib is referenced against Copiktra (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.